Article
A drug-screening platform based on organotypic cultures identifies vulnerabilities to…
bioRxiv · 2020 · Lucía Zhu
Key facts
| Title | A drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent local relapse and treat established brain metastasis |
|---|---|
| First author | Lucía Zhu |
| Journal | bioRxiv |
| Published | Oct 19, 2020 |
| DOI | 10.1101/2020.10.16.329243 |
| Devices mentioned | BK110039, DEN000008, K000534, K003865, K021512, K022086, K023296, K024098, K031824, K031879, K033009, K033185 and 84 more |
| Product codes mentioned | CDS, CEM, CGA, CGZ, CHL, DLJ, GKR, ICC, JCI, JIL, JIT, JIX and 57 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1